Rem3dy Health just closed a £14 million funding round.
The round valued the company at £84 million and was led by Japanese beverage group Suntory, Spanish brewer Estrella Galicia, Indian hospital chain Apollo Hospitals, and French investor X. Other participants included several unnamed strategic investors. The money will fund the rollout of Nourished’s 3D‑printed, individually dosed vitamins beyond the UK.
If the market for personalised nutrition is anything to go by, scaling production is the biggest hurdle. By adding capital, Rem3dy can invest in larger‑scale printers and negotiate bulk ingredient deals, which could lower per‑dose costs and make the service viable in new regions. The backing from diverse global players also gives the startup distribution footholds it lacked before.
Only time will tell if personalised vitamins move beyond a niche curiosity to a regular supplement option.